2022
DOI: 10.3390/jcm11051223
|View full text |Cite
|
Sign up to set email alerts
|

Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein

Abstract: Detailed information regarding lipoprotein concentrations and subfractions in cirrhotic patients before and after orthotopic liver transplantation (OLT) is lacking. Lipoprotein-Z (LP-Z) is a recently characterised abnormal, hepatotoxic free cholesterol-rich low-density lipoprotein (LDL)-like lipoprotein. We determined the lipoprotein profiles, including LP-Z, in cirrhotic patients and OLT recipients and assessed the prognostic significance of LP-Z on the OLT waiting list. We performed analyses in cirrhotic tra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
6
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 61 publications
2
6
2
Order By: Relevance
“…Our findings in LTRs align with previous results showing a 2.4 fold increase in urinary TMAO concentrations in a small group of 40 LTRs, obtained 7 months after transplantation, compared with their levels before the procedure [36]. Complementary to the current report, we previously found that plasma TMAO concentrations tended to be lower in patients with cirrhosis compared with PREVEND participants [30]. Accordingly, circulating TMAO was lower in patients with PSC and impaired liver function compared with healthy controls and patients with ulcerative colitis [31].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Our findings in LTRs align with previous results showing a 2.4 fold increase in urinary TMAO concentrations in a small group of 40 LTRs, obtained 7 months after transplantation, compared with their levels before the procedure [36]. Complementary to the current report, we previously found that plasma TMAO concentrations tended to be lower in patients with cirrhosis compared with PREVEND participants [30]. Accordingly, circulating TMAO was lower in patients with PSC and impaired liver function compared with healthy controls and patients with ulcerative colitis [31].…”
Section: Discussionsupporting
confidence: 92%
“…In cirrhotic livers, FMO3 protein expression is progressively impaired with advancing disease severity [29]. In line, TMAO levels tend to be decreased in patients with endstage liver disease compared with the general population and are inversely associated with the Model for End-stage Liver Disease (MELD) score [30]. TMAO is also decreased in patients with primary sclerosing cholangitis (PSC) and compromised liver function compared with healthy controls [31].…”
Section: Introductionmentioning
confidence: 93%
“…The presence of LP-Z may reflect the inflammatory hepatitis and cholestasis described in both adult COVID-19 ( 66 , 67 ) and up to one third of SARS CoV-2 infections in youth ( 68 ). LP-Z in adults has specifically been linked to worse outcomes in alcoholic cirrhotic disease that also associates with poor HDL function ( 69 ). This is the first description of LP-Z in youth and the increased occurrence not only among youth with MIS-C, but among those with the lowest HDL parameters, is striking.…”
Section: Discussionmentioning
confidence: 99%
“…Lipoprotein particles were measured in EDTA plasma using nuclear magnetic resonance (NMR) spectroscopy with a Vantera ® Clinical Analyzer (Labcorp, Morrisville, NC, USA) [ 34 , 35 ]. Further details regarding this analysis have been published elsewhere [ 36 ]. Small, medium and large HDL particles were quantified using the amplitudes of their spectroscopically distinct methyl group NMR signals [ 35 ].…”
Section: Methodsmentioning
confidence: 99%